{"id":51317,"date":"2026-02-24T12:10:29","date_gmt":"2026-02-24T06:40:29","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=51317"},"modified":"2026-02-24T12:46:50","modified_gmt":"2026-02-24T07:16:50","slug":"lenacapavir-drug","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/lenacapavir-drug\/","title":{"rendered":"Lenacapavir"},"content":{"rendered":"<h2><b>Lenacapavir Latest News<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Recently, Zimbabwe has begun rolling out lenacapavir, a long-acting injectable HIV prevention medicine.<\/span><\/p>\n<h2><b>About Lenacapavir<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is the new long-acting <\/span><b>injectable HIV-prevention drug.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is the <\/span><b>first twice-yearly injectable pre-exposure prophylaxis<\/b><span style=\"font-weight: 400;\"> (PrEP) for HIV, offering a highly effective, long-acting alternative to daily oral pills.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PrEP is a medication that can <\/span><b>reduce the risk of HIV infection for individuals<\/b><span style=\"font-weight: 400;\"> who are HIV-negative but are at risk of contracting the virus.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The results of two key studies have shown that it helps prevent 99.9 per cent of all HIV transmission.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is developed by <\/span><b>Gilead Sciences <\/b><span style=\"font-weight: 400;\">and marketed under the brand name Yeztugo.<\/span><\/li>\n<\/ul>\n<h2><b>How does Lenacapavir work?<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lenacapavir is a <\/span><b>capsid inhibitor,<\/b><span style=\"font-weight: 400;\"> a class of drugs that blocks the protein shell (capsid) the HIV virus needs to replicate.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Unlike oral PrEP pills that must be taken daily, lenacapavir is administered as an injection once every six months, providing a discreet and highly effective method of prevention.<\/span><\/li>\n<\/ul>\n<p><b>Source: <\/b><strong><a href=\"https:\/\/www.downtoearth.org.in\/africa\/zimbabwe-launches-long-acting-hiv-prevention-injection-lenacapavir\" target=\"_blank\" rel=\"nofollow noopener\">DTE<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lenacapavir is a twice-yearly injectable PrEP drug for HIV prevention. Developed by Gilead, it blocks HIV replication and prevents 99.9% of transmission.<\/p>\n","protected":false},"author":24,"featured_media":89607,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[5676,21,23],"class_list":{"0":"post-51317","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-upsc-prelims-current-affairs","8":"tag-lenacapavir","9":"tag-prelims-pointers","10":"tag-upsc-prelims-current-affairs","11":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/51317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=51317"}],"version-history":[{"count":6,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/51317\/revisions"}],"predecessor-version":[{"id":89639,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/51317\/revisions\/89639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/89607"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=51317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=51317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=51317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}